Discover 2,314 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,314
Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery
for
Obesity
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18 - 70
Code: NCT05975580
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: La Jolla CA, San Diego CA, Huntington Beach CA,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: La Jolla CA, Irvine CA, Duarte CA, Eugene OR,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: La Jolla CA, Huntington Beach CA, Torrance CA,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase3, Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Irvine CA, Corona CA, Upland CA, Torrance CA, Duarte CA,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Location: La Jolla CA, Los Angeles CA, San Francisco CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06465810
Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: La Jolla CA, Los Angeles CA, Phoenix AZ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase1, Phase2, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Irvine CA, Riverside CA, Orange CA, Los Angeles CA,